Attributes | Values |
---|
rdf:type
| |
Description
| - Various substituted nitrogen heterocyclic derivatives and their pharmaceutically acceptable salt derivatives are provided for use as medicaments, and particularly, as antimitotic, anti-viral, anti-cancer, anti-degenerative, immunosuppressive, and anti-microbial drugs or, vaccines. These heterocyclic derivatives can be used as an active agent in a pharmaceutical, as well as a diagnostic utility. To this end, several families of heterocyclic derivatives are provided including pyrrolopyrimidines, pyrazolopyrimidines, purines, and imidazopyridines. In particular, certain tri-substituted and tetra-substituted purines and pyrazolopyrimidines and their deaza analogues are provided for inhibiting cyclin-dependent kinase (%22cdk%22) proteins, viruses, and immunostimulation.
- Various substituted nitrogen heterocyclic derivatives and their pharmaceutically acceptable salt derivatives are provided for use as medicaments, and particularly, as antimitotic, anti-viral, anti-cancer, anti-degenerative, immunosuppressive, and anti-microbial drugs or, vaccines. These heterocyclic derivatives can be used as an active agent in a pharmaceutical, as well as a diagnostic utility. To this end, several families of heterocyclic derivatives are provided including pyrrolopyrimidines, pyrazolopyrimidines, purines, and imidazopyridines. In particular, certain tri-substituted and tetra-substituted purines and pyrazolopyrimidines and their deaza analogues are provided for inhibiting cyclin-dependent kinase (%22cdk%22) proteins, viruses, and immunostimulation. (en)
- Substituované deriváty dusíkatých heterocyklických sloučenin a jejich farmaceutické využití. (cs)
|
Title
| - Substituované deriváty dusíkatých heterocyklických sloučenin a jejich farmaceutické využití (cs)
- Substituted nitrogen heterocyclic derivatives and pharmaceutical use thereof
- Substituted nitrogen heterocyclic derivatives and pharmaceutical use thereof (en)
|
skos:prefLabel
| - Substituované deriváty dusíkatých heterocyklických sloučenin a jejich farmaceutické využití (cs)
- Substituted nitrogen heterocyclic derivatives and pharmaceutical use thereof
- Substituted nitrogen heterocyclic derivatives and pharmaceutical use thereof (en)
|
skos:notation
| - RIV/61389030:_____/03:00000302!RIV/2005/AV0/A56005/N
|
http://linked.open...tracePatentuVzoru
| |
http://linked.open...avai/riv/aktivita
| |
http://linked.open...avai/riv/aktivity
| - Z(AV0Z5038910), Z(MSM 153100008)
|
http://linked.open...cisloPatentuVzoru
| |
http://linked.open...eleniPatentuVzoru
| |
http://linked.open...vai/riv/dodaniDat
| |
http://linked.open...aciTvurceVysledku
| |
http://linked.open.../riv/druhVysledku
| |
http://linked.open...iv/duvernostUdaju
| |
http://linked.open...titaPredkladatele
| |
http://linked.open...dnocenehoVysledku
| |
http://linked.open...ai/riv/idVysledku
| - RIV/61389030:_____/03:00000302
|
http://linked.open...riv/jazykVysledku
| |
http://linked.open.../riv/klicovaSlova
| - heterocyclic derivatives (en)
|
http://linked.open.../riv/klicoveSlovo
| |
http://linked.open...ontrolniKodProRIV
| |
http://linked.open.../licencniPoplatek
| |
http://linked.open...ydaniPatentuVzoru
| |
http://linked.open...atelePatentuVzoru
| |
http://linked.open...in/vavai/riv/obor
| |
http://linked.open...ichTvurcuVysledku
| |
http://linked.open...cetTvurcuVysledku
| |
http://linked.open...UplatneniVysledku
| |
http://linked.open...ydaniPatentuVzoru
| |
http://linked.open...iv/tvurceVysledku
| - Hanuš, Jan
- Kryštof, Vladimír
- Strnad, Miroslav
- Veselý, J.
- Hajdúch, M.
|
http://linked.open...avai/riv/vlastnik
| |
http://linked.open...itiJinymSubjektem
| |
http://linked.open...n/vavai/riv/zamer
| |
http://linked.open...stnikPatentuVzoru
| - Ústav experimentální botaniky AV ČR
|